Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience - Quiz - MDSpire

Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience

  • By

  • Mert Tokcan

  • Franciska Diana Wolter

  • Mathias Hohl

  • Peter Fries

  • Thorsten Kessler

  • Saarraaken Kulenthiran

  • Michael Böhm

  • June 3, 2026

  • 0 min

Share

Original Source(s)

Ultrasound common hepatic artery denervation (CHA-D) as a novel neuromodulatory strategy for cardiovascular-kidney-metabolic syndrome: first-in-human experience

  • by Mert Tokcan, Franciska Diana Wolter, Mathias Hohl, Peter Fries, Thorsten Kessler, Saarraaken Kulenthiran, Michael Böhm

  • June 3, 2026

Related Content

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.

COPD Severity Tied to Life Expectancy

A pooled US cohort study estimated years of life lost across airflow obstruction severity, including among adults who never smoked.

Impact of hypertension history and blood pressure parameters on cognitive impairment in patients with atrial fibrillation: a systematic review and meta-analysis